As the HIV research community prepares to convene for the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 ...

Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.

Companies now offer polygenic embryo selection to prospective parents undergoing IVF. But the technology is dangerously underregulated.

Lenacapavir is an approved HIV treatment given as a twice-yearly injection. In 2025, Nigeria joined global leaders in ...

It has taken about two decades, but the world finally has a new, longer-acting injectable drug for HIV prevention. Yesterday, Kenya received 21,000 doses of Lenacapavir, also known as LEN, with about ...

A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that ...

The first batch arrived on Tuesday, February 17, marking a new phase in HIV prevention efforts in the country, where 1.4 ...

Kenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, ...

Background A more nuanced understanding of behavioural responses to incentives over time, particularly after they are removed, could guide more effective interventions. In this study, we build on the ...

Last weekend, communities nationwide marked Black HIV/AIDS Awareness Day, or NBHAAD, during an urgent time for people living with the disease and those who support them. More than four decades after ...

Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving medication and treatment.

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer ...